Therefore, available methods for both HAT and AAT have their limitations–the requirement for a test that enables detection of active infection remains–both for potential utility in the field and to improve, for example, accurate assessment of clinical efficacy of drugs and vaccines (increasing areas of interest for AAT). The gene discussed is SERPINA1; the disease is infection.